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Objective: To evaluate the results of open surgical repair for complications after endovascular thoracic aorta
stenting.
Methods: A total of 14 patients (8 male, mean age 59.8 14.8 years) underwent conventional surgical therapy at
our institution over a 5-year period after previous thoracic aortic stent implantation. The indications for surgery,
intraoperative strategy, and perioperative and follow-up results were analyzed.
Results: The indication for stent implantation was type B aortic dissection in 10 patients, expanding degenerative
thoracic aneurysm in 3 patients, and pseudoaneurysm in 1 patient. The median interval to conventional surgery
after stent implantation was 4.5 months (range 0.1–49 months). The indication for surgery was persistent type I
endoleak with progressive aneurysm enlargement in 7 patients, aortoesophageal fistula in 2 patients, retrograde
type A dissection in 2 patients, infection of the endoprosthesis in 2 patients, and aortic valve insufficiency caused
by perforation of noncoronary and right coronary cusps in 1 patient. The endograft had to be removed in 9 (64%)
patients, and 5 (36%) patients required replacement of the thoracoabdominal aorta. In-hospital mortality was 7%
(1 patient). No patients had a postoperative stroke or paraparesis. Eleven (79%) patients are alive after a mean
follow-up of 13.5  10.1 months (range 1–36 months).
Conclusions: Secondary surgical procedures after stenting of the thoracic aorta can be performed with very good
results, despite the challenging clinical scenarios. Identification of successful surgical strategies for this difficult
clinical problem is important in the era of increasing endovascular therapy.E
TSince its introduction in the early 1990s,1 endovascular
treatment of the descending thoracic aorta has become the
most important therapeutic option for high-risk patients
with thoracic aortic disease. The increasing use and growing
expertise in this field stimulated the expansion of indications
to a wide spectrum of aortic diseases, although the long-term
results of thoracic endografting are still unknown.2 The lim-
itations and late complications associated with endovascular
therapy have become increasingly evident over time.2-6
However, relatively little is known about late complications
of endovascular stenting because of their fairly recent clini-
cal introduction and because few centers have a large clinical
experience. Some groups have reported conventional surgi-
cal procedures for complications associated with endovascu-
lar therapy, but the conclusions from these studies are
limited by their small sample sizes.3,7-9 In this publication,
we present our experience with secondary surgical proce-
dures after thoracic aortic stenting.
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A total of 194 patients underwent thoracic aortic stenting at our institu-
tion and 14 (7.2%) patients (8 male, mean age 59.8  14.8 years) required
subsequent open surgical procedures between July 2002 and August 2007.
Surgical strategies and perioperative and medium-term results were
analyzed.
Endovascular Procedures
The indications for endovascular stent graft treatment of the thoracic
aorta included type B aortic dissection in 10 patients (acute in 1 and chronic
in 9), expanding degenerative thoracic aortic aneurysm in 3 patients (with
contained rupture in 2 patients), and pseudoaneurysm in 1 patient. All pa-
tients with chronic type B aortic dissection had progressive dilatation of
the perfused false channel in the descending thoracic aorta. The indication
for endovascular therapy in acute type B dissection was subtotally narrowed
true channel at the level of the lower abdominal aorta with signs of periph-
eral malperfusion. Four different stent graft systems were used over the
study period: Talent (Medtronic Vascular, Santa Rosa, Calif) in 8 patients,
Excluder (TAG; W. L. Gore & Associates, Inc, Flagstaff, Ariz) in 2 patients,
Endofit (Endomed, Inc, Phoenix, Ariz) in 2 patients, and Valiant (Medtronic
Vascular) in 2 patients. The proximal landing site was distal aortic arch (ie,
proximal to the left subclavian artery) in 8 patients and descending thoracic
aorta in 6 patients. Three patients required more than 1 stent graft implanta-
tion at the time of primary endovascular intervention. Secondary endovas-
cular procedures were performed in 2 patients for persistent type I endoleaks
1 and 4 months after the primary intervention.
Indications for Surgery
The indications for secondary conventional surgical procedures included
progressive enlargement of the aneurysm sac with a type I endoleak in 7 pa-
tients, retrograde type A aortic dissection in 2 patients, aortoesophageal fis-
tula in 2 patients, infection of the endoprosthesis with sepsis in 2 patients,ardiovascular Surgery c Volume 136, Number 5 1289
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CT ¼ computed tomography
and significant aortic valve insufficiency after perforation of the noncoro-
nary and right coronary cusps in 1 patient. The operation was performed
on an emergency basis in 7 patients.
Surgical Procedures
The surgical technique used was dependent on the type of aortic disease
(see below). Full cardiopulmonary bypass or isolated left heart bypass were
used in all patients. The axillary artery was directly cannulated in most pa-
tients requiring surgery on the aortic arch. Selective antegrade cerebral per-
fusion was performed in most of these patients by clamping the
brachiocephalic artery and by inserting a perfusion catheter into the left
common carotid artery. The head was packed externally in ice during circu-
latory arrest.
In the 2 patients with retrograde type A dissection, diagnosed 1 week and
4 months after the endovascular procedure, a median sternotomy was per-
formed. The aortic root procedure was performed during systemic cooling.
When the systemic temperature reached 23C, circulatory arrest was in-
duced and antegrade selective cerebral perfusion was initiated. The distal
aorta was trimmed to the level of the stent graft and an elephant trunk anas-
tomosis, incorporating aortic wall and proximal edge of the stent graft, was
accomplished. The supra-aortic orifices were implanted into the prosthesis
as a Carrel patch.
In 2 patients with type Ia endoleak and isolated enlargement of the distal
arch/proximal descending aorta, surgery was conducted in the same manner
as described above. This approach via a median sternotomy was chosen1290 The Journal of Thoracic and Cardiovascular Suonly if the distal aorta was confirmed to have no endoleak and no enlarge-
ment on serial computed tomographic (CT) scans. For better exposure of the
proximal descending aorta, the incision was extended superiorly in a left an-
terolateral direction. One patient had two previous endovascular reinterven-
tions for type Ia endoleak with the proximal endograft extension abutting
directly onto the bicarotid trunk (Figure 1). The uncovered end and proximal
branches of the stent graft were removed during surgery to produce an ad-
equate anastomotic line, which was performed with an elephant trunk tech-
nique as described above.
The patient with aortic insufficiency caused by leaflet perforation was
operated on 3 days after the endovascular procedure via an upper L-shaped
ministernotomy. Perforation of the noncoronary and right coronary cusps
with adjacent tissue hematoma was confirmed intraoperatively, presumably
caused by guidewire manipulation. Aortic valve reconstruction with an
autologous pericardial patch could be successfully performed.
Open repair was required in 2 patients because of stent graft infection 3.5
months and 1.5 months after the endovascular procedure. The first patient
had recurrent sepsis and a positive white blood cell scan. Because of the
stent graft position in the mid–descending aorta extending to the diaphragm,
a thoracoabdominal incision was used. Left heart bypass was performed
with mild hypothermia (32C) via cannulation of the femoral vessels. The
whole descending aorta along with the infected endoprosthesis was re-
moved and backbleeding intercostal arteries were oversewn. A silver-coated
woven 22-mm Vascutek prosthesis (Sulzer Medica Ltd, Renfrewshire, Scot-
land) was used. The second patient had hemodynamic collapse necessitating
cardiopulmonary resuscitation (CPR) 1 day before the operation, with docu-
mented migration of the stent graft and rupture of the distal aortic arch/prox-
imal descending aorta (Figure 2). Because of the proximal location of the
endoprosthesis and the presence of concomitant coronary artery disease,
a clamshell incision was performed. The distal arch and descending aorta
were replaced with the aid of circulatory arrest at 24C using an extra-ana-
tomically (ie, retrocardially) positioned Dacron prosthesis. Inspection of theFIGURE 1. Persistent type Ia endoleak after two endovascular reinterventions.rgery c November 2008
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Truptured aneurysmal sac revealed a distally migrated stent with complete
leakage of the posterior aortic wall. Both ends of the blind aneurysmal
sac were oversewn and a saphenous vein bypass graft to the right coronary
artery was performed during rewarming.
Two patients underwent emergency surgery for aortoesophageal fistula
49 and 3.5 months after endovascular intervention. The first patient was
brought to our hospital with massive hematemesis and cardiopulmonary re-
suscitation with blood aspiration, and surgery was performed under emer-
gency, extremely high-risk conditions. Because of the proximal location
of the stent graft, a median sternotomy with left anterolateral extension
into the second intercostal space was chosen. The distal elephant trunk anas-
tomosis was performed to the mid–descending thoracic aorta after com-
pletely removing the stent under hypothermic circulatory arrest (22C).
Inspection of the esophagus showed a wall defect 2.5 cm in diameter, which
was closed with interrupted sutures and covered with an autologous pericar-
dial patch. The patient had to be reoperated on for recurrent esophageal leak-
age with signs of mediastinitis 2 weeks after the initial operation. He was
treated by an esophagectomy with closure of the distal esophageal stump
and cervical esophagostomy. The second patient with an aortoesophageal
fistula was referred from a peripheral hospital 3.5 months after stent graft
placement for contained rupture of a distal descending aneurysm. The gas-
troscopy and CT scan (Figure 3) demonstrated stent graft protrusion through
the anterior aortic wall into the esophagus. Surgical exposure was achieved
through a thoracoabdominal incision. After removal of the endoprosthesis,
the descending aorta was replaced with a Dacron vascular graft. Resection
of the perforated esophageal segment (Figure 3) with oversewing of the
FIGURE 2. Mycotic aortic aneurysm after stent graft implantation.The Journal of Thoracic and Caproximal and distal stumps was performed at the first stage. Esophageal
continuity was restored 7 days later with a gastric pull-up procedure.
The remaining 5 patients with chronic type B dissection were operated
on for persistent type I endoleak associated with continuous enlargement
of the whole thoracoabdominal aorta. Four of these patients had residual
false channel perfusion directly after stent implantation and 1 patient had
a secondary type Ib endoleak. A thoracoabdominal incision was used for
surgical exposure in all cases. Cerebrospinal fluid drainage to minimize
the risk of paraplegia was used routinely, with a goal to keep the pressure
below 10 cm H2O. Three patients required circulatory arrest because of
proximal extension of the stent graft into the aortic arch (ie, directly adjacent
to the origin of the left carotid artery). Circulatory arrest was induced at
22C while the aorta was crossclamped on the lower descending segment.
The lower body was subsequently perfused at 1.0 L/min via the femoral can-
nula. The stents were completely removed and an open distal hemiarch re-
placement was accomplished with a Dacron prosthesis with a sidearm graft.
Perfusion of the upper body was restored via the sidearm of the prosthesis
after careful deairing of the heart and supra-aortic vessels. The abdominal
aorta was replaced with a Dacron graft under selective perfusion of the ab-
dominal organs with cold blood. Distal perfusion was reinstituted via the
femoral cannula, and the proximal-to-distal prosthetic anastomosis was ac-
complished as the last stage. The sidearm of the proximal prosthesis was
used for the reconstruction of the left subclavian artery. Two patients with
the more distal location of the aortic endoprosthesis in the descending aorta
were operated on with the aid of left heart bypass and mild hypothermia
(32C).
Statistical Analysis
Standard definitions were used for patient variables and outcomes. Op-
erative mortality was defined as death during hospitalization. Categorical
variables are expressed as percentages and continuous variables are ex-
pressed as mean  SD throughout the manuscript. All statistical analyses
were performed with the SPSS 14.0 software (SPSS, Inc, Chicago, Ill).
Long-term survival was analyzed with the Kaplan–Meier method.
RESULTS
The median time interval between endovascular interven-
tion and secondary surgical procedure was 4.5 months
(range 3 days to 49 months). Proximal intimal tears were
found in both patients with type A dissection, located in
the ascending aorta in the first and in the distal arch (proxi-
mal landing zone of the stent) in the second patient. All 7 pa-
tients operated on for type I endoleak showed insufficiently
sealed entry sites intraoperatively.FIGURE 3. Protrusion of the stent graft into the esophagus.rdiovascular Surgery c Volume 136, Number 5 1291
Evolving Technology Girdauskas et al
E
TThe duration of cardiopulmonary bypass or left heart
bypass was 162  70 minutes. Aortic crossclamping was
required in 10 patients with a mean time of 80 38 minutes.
Nine patients had to be operated on with the aid of circula-
tory arrest (mean duration 25  17 minutes) at a rectal
temperature of 22.3C  1.1C. Simultaneous selective
antegrade cerebral perfusion was performed in 6 of these
patients. The stent grafts were removed in 9 (64%) and
left in situ in the remaining 5 patients.
One patient died while in the hospital, for a mortality rate
of 7.1%. The predicted logistic EuroSCORE risk of mortal-
ity for the entire patient cohort was 39.4%  25.6%. The
single patient who died was the one with aortoesophageal
fistula who required reoperation for recurrent esophageal
leakage and mediastinitis. He died of septic multiorgan fail-
ure after a 39-day stay in the intensive care unit.
The median length of stay in the intensive care unit was
3 days (range 1–39 days). Four (28.6%) patients required
reoperation because of excessive postoperative bleeding.
The median time supported by mechanical ventilation was
26 hours (range 7–960 hours). Two patients required
temporary tracheostomy for prolonged weaning from the
mechanical ventilator. No new neurologic deficits (stroke
or paraplegia) were observed postoperatively. Preoperative
paraplegia persisted in 1 patient who was admitted with
a contained rupture of the distal false channel. The hospital
stay ranged from 8 to 40 days postoperatively (mean stay
20.1  10.1 days). Predischarge echocardiography in the 2
patients who underwent aortic valve repair (ie, pericardial
patch repair and David procedure) revealed mild and trivial
aortic insufficiency, respectively.
Follow-up information was available for all discharged
patients. After a mean follow-up period of 13.5  10.1
months (range 1–36 months), 11 patients were alive and do-
ing well. No aortic reinterventions were required in any pa-
tient. A total of 2 patients died during follow-up. The first
patient underwent repair of a type A dissection and died sud-
denly while in convalescence. No autopsy was performed.
The second patient died 1.5 months after aortic arch replace-
ment for type Ia endoleak as a result of necrotizing pancre-
atitis. One- and 2-year survival was 78%  11.3%.
DISCUSSION
With the growing number of interventional thoracic aortic
procedures and liberalization of indications, the number of
patients requiring open surgery after stent implantation
may be increasing. Several surgical groups have reported
their initial experience with open repair of different diseases
of the thoracic aorta after endovascular therapy.2,7-9 Our
own data show a tendency toward a growing incidence of
secondary surgical interventions in more recent years (6 pa-
tients in 2007 compared with 3, 1, and 2 patients in the pre-
vious years). As described above, the indications for open
surgery consisted of expanding aortic aneurysm, retrograde1292 The Journal of Thoracic and Cardiovascular Sutype A dissection, infected stent graft prosthesis, aortoeso-
phageal fistula, and acute aortic valve insufficiency.
The reported incidence of retrograde type A dissection af-
ter thoracic stent graft implantation worldwide is approxi-
mately 1% to 2%, although some groups published a rate
of 5% to 6.8%.3,10 Both of our patients with type A dissec-
tion underwent a prior endovascular procedure for chronic
type B dissection with positioning of the proximal stent graft
in the distal aortic arch.2,9,10 One of the 2 patients underwent
endovascular reintervention for type Ia endoleak 1 month af-
ter initial stent graft deployment, with repeated balloon dila-
tations to achieve a tight seal. It is plausible that a type A
dissection in this case was triggered by repeated endoaortic
manipulations (eg, wire and sheath manipulation or balloon
dilatation). Furthermore, an intramural hematoma involving
the aortic arch and ascending aorta could be identified on the
preprocedural CT scan retrospectively, performed before the
initial endovascular procedure. Intramural hematomas in
the stent graft landing areas in the distal aortic arch (ie,
covering the left subclavian artery) in patients with type B
dissection have been reported to predispose to formation
of retrograde dissection.2,3 Excessive angulation (70) of
the aortic arch was also noted in our patient. The second
patient reported having mild nonspecific chest pain after
her endovascular procedure. We were surprised to find a ret-
rograde type A dissection on routine CT scan performed
1 week after the intervention. This finding reinforces the
importance of postprocedural surveillance CT scans.
Perforation of the right and noncoronary aortic valve
cusps was seen in 1 of our patients. To the best of our knowl-
edge, such a complication has not been previously published
in the literature. The cause of this adverse event was presum-
ably guidewire manipulation during stent implantation. For-
tunately, valve repair with autologous pericardial patch
augmentation was successful in this 23-year-old female pa-
tient.
Two patients in our series underwent surgery for endo-
prosthesis infection, which was confirmed by culture of
the explanted endograft and aortic thrombus (Staphylococ-
cus aureus in the first and Staphylococcus epidermidis in
the second patient). The relatively short time interval after
endovascular intervention (3.5 months and 1.5 months, re-
spectively) indicates a periprocedural infection. Moreover,
both of these patients had evidence of systemic inflamma-
tory reaction after the endovascular intervention. An exten-
sive inflammatory process of the posterior mediastinum with
contained aortic rupture required an extra-anatomic solution
in 1 patient. No signs of recurrent infection have occurred in
these patients during follow-up. Alternatively, thoracic aor-
tic homografts have been successfully used in selected cases
of infected thoracic aortic fabric grafts, aortoesophageal
fistulas, and other situations.11
Aortoesophageal fistula is an uncommon but well de-
scribed complication after thoracic aortic stenting.4,5,12,13rgery c November 2008
Girdauskas et al Evolving TechnologyFIGURE 4. Type Ib endoleak after stenting of chronic type B dissection.E
TSuggested mechanisms leading to aortoesophageal fistula
formation are chronic endoleak leading to erosion into the
adjacent esophagus, penetration of the stent graft through
the aortic wall into the esophagus,4 and ischemic necrosis
of the esophageal wall resulting from stent coverage of the
arteries in the midesophageal segment.5 Our first patient
had a stent deployed in the distal aortic arch because of de-
scending aortic aneurysm and was monitored closely for 14
months because of secondary type Ib endoleak. Chronic en-
doleak was therefore the most likely mechanism of the aor-
toesophageal fistula. The second patient had a documented
erosion of the esophageal mucosa before stent graft implan-
tation, which had progressed to a large esophageal ulcer
(43 3 cm) 3 months after endovascular sealing of a ruptured
mid–descending thoracic aortic aneurysm. This clinical sce-
nario is suggestive of ischemic pathogenesis of the fistula.
Multiple combinations of treatment options have been
used to deal with aortoesophageal fistula, including in situ
arterial reconstruction, extra-anatomic bypass with concom-
itant primary esophageal repair, or esophagectomy with
cervical esophagostomy and secondary restoration of gastro-
intestinal tract continuity. Conservative, nonsurgical therapy
results invariably in a fatal outcome owing to massive hem-
orrhage or chronic mediastinitis.4 After having lost our first
patient as a result of recurrent esophageal leakage 2 weeks
after primary defect repair, we changed our surgical strategy
toward a more radical approach consisting of esophageal
resection and restoration of esophagogastric continuity
using a gastric pull-up procedure at the second stage. Our
second patient survived uneventfully.The Journal of Thoracic and CPersistent type I endoleak with progressive increase in an-
eurysm size is one of the major limitations of endovascular
treatment. In our series, all 7 patients operated on for type I
endoleak underwent initial endovascular intervention for
type B dissection (chronic dissection in 6 patients and acute
in 1). Despite aggressive oversizing, primary type I endoleak
was documented in 6 patients, although additional stent im-
plantations and repeated balloon dilatations were tried to
seal them during the initial procedure (Figure 4). Because
of proximal stent extension into the distal aortic arch to cover
the entry site close to the left subclavian artery, an extensive
open repair with prolonged circulatory arrest was required
to repair the aortic arch in these patients. However, it is
important to note that none of the patients in our series
had a perioperative stroke or new paraplegia. We believe
our perioperative strategies, including selective antegrade
cerebral perfusion, drainage of cerebrospinal fluid, and distal
perfusion of the lower body enabled us to avoid neurologic
complications in these complex aortic arch procedures.
Endovascular stent grafting is an established treatment
modality of the thoracic aorta, with particular benefits in
emergency situations (eg, traumatic aortic transection, rup-
tured descending aortic aneurysm, or complicated acute
type B dissection). Chronic type B dissections have been
identified through growing clinical experience to be the
most challenging clinical scenario for the endovascular ther-
apy. The reasons for the increased complexity include the
need to cover the distal aortic arch, the challenging anatomic
characteristics of the chronically dissected aorta (ie, subto-
tally narrowed true lumen and rigid intimal membrane thatardiovascular Surgery c Volume 136, Number 5 1293
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Tprevents expansion of the true lumen), and the inability to
address the abdominal segment between the celiac trunk
and the renal arteries, therefore leaving untreated dissected
aorta with potentially distally located re-entry sites (Fig-
ure 4). Such reasons explain the relatively high incidence
of persistent endoleaks, endovascular reinterventions, and
secondary surgical procedures in this patient subgroup. In
our own experience, 9 (64%) of 14 open surgical procedures
after endovascular therapy were required in patients with
previous chronic type B dissection. This experience points
out the importance of appropriate patient selection for endo-
vascular therapy. It may therefore be necessary to re-exam-
ine the indications for endovascular therapy in chronic type
B dissections, considering that conventional surgical ther-
apy may still be required in a significant proportion of these
patients. The reported rate of persistent endoleaks, endovas-
cular reinterventions, and deaths resulting from aortic rup-
ture after thoracic aortic endovascular therapy, even from
the leading interventional groups,6,10,14 underscores the
fact that conventional surgical therapy should not be com-
pletely abandoned in this patient population. Although en-
dovascular repair has revolutionized aortic surgery, careful
evaluation and appropriate indication for this treatment
modality remain essential.
Study Limitations
The limitation of our study is the small sample size, which
markedly limits the statistical analyses that can be per-
formed. However, to the best of our knowledge, our series
is the largest to date in the literature. As the number of pa-
tients undergoing thoracic endovascular therapy continues
to grow over time, we believe our in-depth description of
the presentation and management of these patients will
provide helpful insights for clinicians who are increasingly
likely to encounter these very challenging clinical problems.
CONCLUSIONS
Secondary conventional surgical procedures after thoracic
aortic stenting can be performed with low perioperative and
medium-term risk, despite the precarious preoperative status1294 The Journal of Thoracic and Cardiovascular Suand increased technical challenge presented by such pa-
tients. The precise analysis of the midterm and long-term re-
sults of endovascular therapy may identify patients who are
more likely to benefit from primary conventional surgery.
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